PS Ratio Chart

View PS Ratio for SRRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2019. Start Trial.
Date Value
March 30, 2023 12.10
March 29, 2023 12.27
March 28, 2023 11.64
March 27, 2023 12.67
March 24, 2023 12.36
March 23, 2023 13.62
March 22, 2023 14.48
March 21, 2023 14.84
March 20, 2023 14.45
March 17, 2023 14.87
March 16, 2023 15.81
March 15, 2023 16.35
March 14, 2023 16.28
March 13, 2023 15.06
March 10, 2023 14.45
March 09, 2023 15.60
March 08, 2023 15.79
March 07, 2023 15.70
March 06, 2023 14.73
March 03, 2023 14.24
March 02, 2023 14.07
March 01, 2023 13.56
February 28, 2023 13.58
February 27, 2023 13.48
February 24, 2023 13.29
Date Value
February 23, 2023 13.94
February 22, 2023 14.43
February 21, 2023 14.86
February 17, 2023 15.46
February 16, 2023 15.55
February 15, 2023 15.74
February 14, 2023 15.95
February 13, 2023 15.82
February 10, 2023 17.20
February 09, 2023 18.21
February 08, 2023 18.89
February 07, 2023 19.83
February 06, 2023 19.49
February 03, 2023 19.73
February 02, 2023 19.57
February 01, 2023 19.35
January 31, 2023 19.15
January 30, 2023 19.27
January 27, 2023 20.03
January 26, 2023 19.81
January 25, 2023 19.51
January 24, 2023 20.00
January 23, 2023 18.81
January 20, 2023 18.32
January 19, 2023 18.04

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Biogen, Inc. 3.043
Agenus, Inc. 0.9072
Amgen, Inc. 5.100
BioCryst Pharmaceuticals, Inc. 2.157
Imunon, Inc. --

PS Ratio Related Metrics

PEG Ratio -0.3461
Price to Book Value 19.06
Price 44.18
Earnings Yield -8.12%
Market Cap 5.262B
PEGY Ratio -0.3461